Capital Investment Counsel Inc Has $478,000 Holdings in The Clorox Company (NYSE:CLX)

Capital Investment Counsel Inc cut its position in shares of The Clorox Company (NYSE:CLX) by 5.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 2,936 shares of the company’s stock after selling 164 shares during the quarter. Capital Investment Counsel Inc’s holdings in Clorox were worth $478,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. GoalVest Advisory LLC acquired a new stake in shares of Clorox during the first quarter worth $31,000. First Foundation Advisors acquired a new stake in shares of Clorox during the first quarter worth $31,000. Innealta Capital LLC acquired a new stake in shares of Clorox during the second quarter worth $30,000. Trifecta Capital Advisors LLC grew its holdings in Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after purchasing an additional 130 shares during the period. Finally, Quarry LP grew its holdings in Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock worth $31,000 after purchasing an additional 114 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CLX has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft raised their price target on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and raised their price target for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. Wells Fargo & Company reduced their price target on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a report on Wednesday, July 10th. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. Finally, DA Davidson restated a “neutral” rating and issued a $153.00 price target on shares of Clorox in a report on Friday, September 6th. Six research analysts have rated the stock with a sell rating, nine have issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $150.14.

Clorox Stock Down 0.1 %

Clorox stock opened at $159.04 on Thursday. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.09. The stock has a market cap of $19.75 billion, a PE ratio of 82.40, a price-to-earnings-growth ratio of 3.19 and a beta of 0.41. The firm’s 50-day simple moving average is $160.25 and its 200 day simple moving average is $145.43. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03.

Clorox (NYSE:CLX) last released its quarterly earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The business had revenue of $1.90 billion for the quarter, compared to analysts’ expectations of $1.97 billion. Research analysts predict that The Clorox Company will post 6.64 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a yield of 3.07%. The ex-dividend date is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is presently 252.85%.

Insiders Place Their Bets

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.51% of the company’s stock.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.